Journal article
Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study
Abstract
BACKGROUND: The risk of recurrent venous thromboembolism (VTE) in cancer patients despite anticoagulant therapy is high. Clinical factors and pro-coagulant markers may identify high-risk patients and guide decisions about intensifying anticoagulation therapy.
AIMS: To evaluate whether serial measurements of pro-coagulant markers can identify patients at high risk of recurrent VTE.
Authors
van Es N; Louzada M; Carrier M; Tagalakis V; Gross PL; Shivakumar S; Rodger MA; Wells PS
Journal
Thrombosis Research, Vol. 163, , pp. 41–46
Publisher
Elsevier
Publication Date
March 2018
DOI
10.1016/j.thromres.2018.01.009
ISSN
0049-3848